Cardiology
FDA/CDC
Stryker issues voluntary field action for Lifepak 15 defibrillators
The field action includes 13,003 devices.
Latest News
AHA report highlights CVD burden, declines in smoking, sleep importance
Nearly half of Americans now have high blood pressure, in part due to the 2017 redefinition of hypertension.
Clinical Review
Assessment of Cardiovascular Disease Risk in Rheumatoid Arthritis
Conference Coverage
Aspirin for primary cardiovascular prevention, RIP
SNOWMASS, COLO. – “Is aspirin safe and effective for primary prevention? The short answer here is no.” –Dr. Patrick T. O’Gara
Latest News
Revised U.S. A fib guidelines revamp anticoagulation
The first revision of U.S. guidelines for managing atrial fibrillation since 2014 favor DOACs over warfarin.
Conference Coverage
Obesity paradox applies to post-stroke mortality
Conference Coverage
SGLT-2 inhibitors promising for heart failure prevention, not treatment
LOS ANGELES – The combination of heart failure and diabetes is particularly lethal.
FDA/CDC
Torrent Pharmaceuticals expands losartan recall
Ten more lots recalled.
Conference Coverage
New diabetes drugs solidify their cardiovascular and renal benefits
CHICAGO –
News
Hospital Readmissions Reduction Program may be doing more harm than good
Thirty-day postdischarge mortality went up after the program for some, down for others.